The prevalence of MSI-H in sporadic CRC has drawn attention to methylation of MLH1 promoter regions as the potential mechanism underlying MSI in these cancers (Cunningham et al, 1998; Herman et al, 1998). This evidence concerns the gene MLH1 and cancer.